Graphical abstract1 2 2
Introduction

50
Phthalate esters (PEs) are plasticiser additives enhancing durability, elasticity and flexibility 51 in consumer and polymeric products 1 . Low molecular weight (LMW) PEs such as dimethyl 52 phthalate (DMP) and diethyl phthalate (DEP) are added as synthetic stabilisers to industrial 53 solvents and personal care products they are also used as colouring or fragrance additives 2, 3 . 54
High MW (HMW) PEs such as di-(2-ethylhexyl) phthalate (DEHP) and di-iso-nonyl 55 phthalate (DiNP) are primarily used in polyvinyl chloride (PVC) products including floor 56 polishing, wall coatings, children's toys, medical products and food packaging [4] [5] [6] . Their low 57 migration stability and vapour pressure influence PE release to the indoor environment, 58 resulting in their classification as major indoor organic contaminants 7, 8 . Consequently, 59
considerably high levels of PEs have been found in indoor dust worldwide 5, [9] [10] [11] [12] [13] . 60
Human exposure to PEs in the indoor environment is a phenomenon of growing concern due 61 to the potentially adverse health effects of PEs such as DEHP, di-n-butyl phthalate (DnBP) 62 and di-iso-butyl phthalate (DiBP) in adults, such as disrupted endocrine and thyroid 63 homeostasis, reduced fertility and reproduction 3, 14, 15 . Hence, the US and the EU have partly 64 restricted the use of DiBP, DnBP, and DEHP in toys and childcare products 16, 17 . Such 65 actions paved the way for the introduction of less toxic, non-phthalate substitutes (i.e. 66 alternative plasticisers) in consumer products in the early 2000s, such as di-isononyl-67 cyclohexane-1,2-dicarboxylate (DINCH; DEHP and DiNP replacement) and bis ethylhexyl) terephthalate (DEHT), a structural isomer of DEHP [18] [19] [20] [21] . However, due to their 69 dominant use and rapid substitution, considerable levels of DINCH and DEHT have been 70 reported in the indoor environment, raising concerns about their potential effects on humans 71 [22] [23] [24] [25] . 72
Due to their critical and vulnerable developmental status, pre and postnatal children's 73 exposure to PEs via indoor dust and PVC materials has been linked with chronic respiratory 74 problems such as allergies, asthma, bronchial hyperactivity and inflammation, as well as 75 neurodevelopmental disorders manifesting in adulthood [26] [27] [28] [29] [30] [31] . Franken et al. (2017) reported 76 the high occurrence of asthma in Belgian teenagers (especially girls) associated with high 77 DEHP and DnBP exposure 32 . DEHT and DINCH administration to rodents revealed no signs 78 of DEHP-like toxicity [33] [34] [35] . However, DINCH in utero exposure has been associated with 79 signs of impaired liver metabolism and premature testicular aging such as decreased 80 testosterone secretion, physical changes in seminal glands and testicular atrophy in rats and 81 6 their young offspring 36 . Thus, the debate regarding the safety of alternative plasticisers is 82 ongoing especially during early-life exposure. 83
Physiologically-based extraction tests (PBET) have been employed to assess the oral 84 bioaccessibility (i.e. uptake) of PEs via dust ingestion [37] [38] [39] . PE gut bioaccessibility decreased 85 as logKow increased; LMW PEs such as DMP and DEP were found to be 32 % and 26 % 86 bioaccessible, respectively, while DEHP was only 10 % bioaccessible via the gut 38 . In a 87 comparative study between different dust size fractions and oral bioaccessibility, Wang et al. 88 (2013) reported the highest gut uptake for LMW PEs in < 63 μm size fraction, compared to 89 particles > 63 μm 39 . Dermal absorption of DEP and DnBP directly from air has been 90 proposed by Weschler et al 40 .
Since no studies exist regarding the inhalation bioaccessibility 91 of organic pollutants, this calls for their development 41 . 92
This is the first study we are aware of quantifying the inhalation bioaccessibility of PEs and 93 alternative plasticisers employing two artificial lung fluids, mimicking two distinctively 94 different interstitial lung conditions. Artificial pulmonary fluids have been previously 95 employed in inhalation bioaccessibility studies of water-soluble metals and nanoparticles 42- 
Material and methods
106
Sampling and dust particle properties 107
Details on the A-TEAM sampling protocols are given elsewhere 47 . Pre-existing vacuum 108 cleaner dust samples (N=10) were passed through a methanol-washed, metallic sieve (< 63 109 μm) with respect to the inhalable aerodynamic particle cut off convention according to the 110
International Organization for Standardization (ISO) 48 . Specific surface area and dust particle 111 size were determined by laser diffraction spectroscopy (Mastersizer 3000, Malvern Ltd.,7 UK), while total carbon (TC %) and nitrogen (TN %) contents were determined by Thermo 113
Flash 2000 and organic matter content (OMC %) was determined by loss-on-ignition (LOI) 114 as described elsewhere 49 . 115
Dust extraction and clean-up 116
Details of the indoor dust extraction have been published previously 24, 50 . Briefly, 100 mg of 117 dust (< 63 μm) were extracted with 10 mL acetone: n-hexane (1:1 v/v) using microwave-118 assisted extraction (MAE) under controlled pressure and temperature. Prior to extraction, 400 119 ng ISTD mix prepared in n-hexane (DMP-d4, DnBP-d4 and DEHP-d4) were spiked into all 120 samples. The dust extracts were concentrated to 0.5 ml under a gentle nitrogen (N2) stream 121 which was filtrated through a glass Pasteur pipette tip containing charcoal in order to 122 eliminate any traces of external contamination and the solvent was exchanged to n-hexane. 123
This solution was loaded onto an ENVI-Florisil cartridge (500 mg / 3 mL, Biotage Isolute, 124
Uppsala, Sweden) and 9 mL of n-hexane were added as a cleaning elution step. During the 125 second elution, all target analytes were eluted using the 9 mL acetone: n-hexane (1:1) and the 126 resulting eluate was concentrated to 1 ml with a gentle N2 flow at room temperature, filtered 127 as described above. Finally, all extracts were transferred to GC vials and biphenyl (300 ng) 128 was added as an injection recovery standard prior to GC-MS/MS analysis (Fig SI 1) . Further 129 details about instrumental analysis are available in SI. 130
Lung fluid extraction 131
All lung fluid extractions were conducted in duplicate. Both media were freshly prepared 24 132 h before the initiation of each test in ultra-pure H2O (18.2 Ω) as described elsewhere 43 (Table  133 SI 3), pH-adjusted using HCl 1 M and NaOH 1 M, stored at 4°C and were checked for 134 background phthalate contamination prior use. According to Boisa et al (2014) , the 135 experimental volume for simulated lung fluid extraction tests should be equal to 20 mL, 136 given the pulmonary fluid volume capacity of healthy non-smoking adults (0.3 mL / kg; 70 137 kg body mass) 42 . In order to maintain 1:100 solid-to-liquid (S/L) ratio between the incubated 138 matrix and the pulmonary fluid, 0.2 g of indoor dust (< 63 μm) were combined with 20 mL of 139 each artificial lung fluid separately, as suggested by Schaider et al 51 . All samples were 140 covered on top with oven-baked aluminium foil to avoid background phthalate 141 contamination, followed by continuous incubation inside a thermostatic chamber (60 rpm; 37 142 °C) for 96 h , a time point relevant to the human alveolar clearance capacity 45, 52 . After 96 h, 143 the samples were separated by centrifugation (1500 rpm; 3 min) and the lung supernatants8 were subjected to liquid-liquid extraction (LLE) using 7 mL Hexane: MTBE 3:1 twice, while 145 ultrasonication-assisted extraction was employed for the residual dusts twice for 10 min using 146 7 mL of Acetone: Hexane 1:1. Prior to all extractions, all samples were spiked with 400 ng 147 ISTD mix prepared in n-hexane (DMP-d4, DnBP-d4 and DEHP-d4). To avoid any water 148 residue and remove any gel-like emulsion formulated during LLE, sufficient amount of oven-149 baked Na2SO4 (powder) was added to all extracts, followed by 1 min vortexing and organic 150 phase collection after centrifugation (1500 rpm; 3 min). All extracts were combined, solvent 151 was exchanged to n-hexane and concentrated to 1 ml under a gentle N2 stream at room 152 temperature, filtered as described above. The residual dust extracts were subjected for clean-153 up through ENVI-Florisil SPE cartridge (500 mg / 3 mL, Biotage Isolute, Uppsala, Sweden), 154 similarly to the dust extraction procedure described above. Briefly, the residual dust extracts 155 were loaded onto the Florisil ® columns, the first hexane eluate was discarded, while the 156 second eluate was collected using 9 mL of MTBE. The resulting eluate was concentrated to 1 157 ml under a gentle N2 flow at room temperature, filtered as described above. Finally, all 158 extracts were transferred to oven-baked GC vials and biphenyl (300 ng) was added as an 159 injection recovery standard prior to GC-MS/MS analysis (Fig SI 2) . 160
Data analysis 161
Inhalation bioaccessibility (IBAF) was determined using Eq. 1, where mass phthalate (lung 162 supernatant) is set as the phthalate mass (ng) determined in the lung supernatant of the in 163 vitro pulmonary system and mass phthalate (dust residual) is the mass (ng) determined in the 164 dust residual collected after the 96 h-incubation of the in vitro pulmonary system which is 165 considered as the non-bioaccessible fraction. 166
GraphPad Prism ® version 7.00 for Windows, (GraphPad Software, La Jolla CA, USA) was 170 used for statistical analysis. Prior to statistical analysis, all data were checked for normality 171 using the Shapiro-Wilk test and not all data passed the normality test. All data were arc-sine 172 transformed, as this mathematical transformation is necessary for statistical analysis of results 173 set in percentages in order to equalise variances among treatments 53 . Ordinary two-way 174 ANOVA (Uncorrected Fisher's test, p<0.05) was performed to assess statistically significant9 differences of target analytes between both pulmonary fluids. Spearman's correlation 176 (p<0.05) was employed to assess statistical dependence and correlation between artificial 177 lung fluids and the physicochemical properties of all target analytes. 178
Quality assurance and quality control 179
The methods were evaluated using SRM 2585 as QC sample during dust (n=5) and lung fluid 180 (n=4) extractions, respectively. Oven-baked, uncontaminated sand was used as a procedural 181 blank during dust extractions; four blank lung fluid samples with no added matrix (two for 182 each lung fluid) were sequentially incubated and analysed as procedural blanks. The results 183 were blank-corrected for all target analytes by subtraction of the mean blank values from the 184 raw target analytes values (expressed in ng g -1 ) according to Abdhalah and Covaci 54 . 185
Extraction efficiency for all target analytes ranged from 70 -120% for both lung fluids 186 respectively (Table SI 6 ). Method limits of detection (mLOD) were calculated as three times 187 the standard deviation of the lung fluid blanks (Table SI 7) . 188
Results and discussion
PEs and alternative plasticisers in indoor dust 190
Apart from DEHT, levels of PEs and DINCH from floor (N=61) and vacuum cleaner dust 191 (N=58) from the ATEAM cohort have been previously reported 23 and were of the same order 192 of magnitude as reported here (N=10; SI ). These findings can be attributed to a) differences in sample size assessed and b) 199 differences in particle size cut off and specific surface area which are likely to influence a 200 pollutant's concentration in dust 39, 55 . However, the aim of the present study is primarily to 201 assess the inhalation bioacceessibility of PEs and their alternatives plasticisers, rather than 202 report on their levels in dust. 203
Inhalation bioaccessibility 204
This is the first study on the in vitro inhalation bioaccessibility of PEs and alternative 205 plasticisers via indoor dust. Inhalation bioaccessibility for DMP and DEP exceeded 70 % in 206 both pulmonary media (Fig. 1) interstitial macrophages within the lung 42, 43 . Hence, the inhaled dust particles would not have 215 to be phagocytised before a considerable uptake of plasticisers occurs, with the exception of 216
DMP. 217
Similarly to gut bioaccessibility which is partly governed by a pollutant's physico-chemical 218 properties including MW and log Kow 56, 57 , inhalation bioaccessibility of PEs decreased 219 against the increasing trend in MW and log Kow (> 4). DiBP pulmonary uptake was 15.5 % 220 and 12 %, in Gamble's solution and ALF, respectively, whereas DnBP and HMW PEs were 221 10 % and < 5 % bioaccessible in both media, including DEHP and its alternatives, DEHT and 222 DINCH (Fig 1) . Such findings endorse ingestion (food or dust) and dermal uptake as the 223 predominant exposure routes for medium and HMW PEs, strongly influenced by their 224 hydrophobic character and low water solubility 6, 23, 38 . However, no consensus exists 225 regarding pulmonary media composition for inhalation bioaccessibility studies of organics. 226
Employing modified media formulations with the addition of biologically relevant pulmonary 227 surfactants such as albumin, mucin and dipalmitoylphosphatidylcholine (DPCC) have been 228 proposed 41, 42, 58 ; the case of DPCC makes biological sense and it should be thus 229 systematically investigated along with other test parameters including S/L, incubation 230 duration and particle size cut off 41, 59 , aiming towards a unified approach similarly to gut 231 bioaccessibility 56 . 232
Method performance using SRM 2585 233
Method performance was assessed using SRM 2585, since the pulmonary media used here 234 were initially designed for nanoparticle and trace element inhalation bioaccessibility 235 11 studies 43, 45, 60 . IBAF > 75 % was found for LMW PEs, while DEHP and DiNP were the least 236 bioaccessible (IBAF < 5 %) as highly hydrophobic compounds (Table 1) , following a 237 comparable pattern to the Norwegian house dust IBAF results. The SRM 2585 batch 238 purchased in our study was prepared using a pool of dust samples collected during mid to late 239 1990s. Thus, DINCH and DPHP were not detected, since they were introduced in the market 240 after 2000 18, 61 . 241
In this study we propose an in vitro method regarding the inhalation bioaccessibility of PEs 242
and their alternatives via indoor dust. Low MW PEs such as DMP and DEP were highly 243 bioaccessible in both artificial pulmonary media (> 75 %), regardless of the medium's pH 244 and composition. Unlike DEP which presented similar pulmonary uptake in both media, 245 DMP was more readily absorbed through ALF than Gamble's solution. HMW PEs along with 246 DEHP alternatives, DEHT and DINCH did not exceed 5 % pulmonary uptake. Therefore, 247
inhalation is a considerable route of exposure for LMW and less hydrophobic PEs. 286 † Physicochemical properties of plasticisers studied here can be found at Table SI xxx   287 
